Go Jai Hyang, Kim Dae Shick, Kim Tae Jin, Ko Young H, Ra Hyun Ki, Rhee Jong Chul, Kim Seon Woo, Ree Howe J
Samsung Medical Center/Sungkyunkwan University School of Medicine, Seoul, Korea.
Arch Pathol Lab Med. 2003 Nov;127(11):1443-50. doi: 10.5858/2003-127-1443-CSOSAO.
Many diffuse large B-cell lymphomas (DLBCLs) of the stomach are believed to represent high-grade transformation of low-grade marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type, which is of memory B-cell origin, displaying evidence for positive antigen selection and a low level of ongoing somatic mutation of the rearranged immunoglobulin heavy-chain variable region (V(H)) genes. The pattern of somatic mutation has been studied little in intestinal DLBCLs.
To assess evidence for antigen selection and the levels of ongoing mutation, we analyzed the ratio of replacement to silent mutations, as well as the frequency of intraclonal sequence variation in gastric and small intestinal DLBCLs that showed no concomitant low-grade component.
Genomic DNA was extracted from formalin-fixed paraffin blocks of gastric (n = 6) and small intestinal (n = 6) DLBCLs. The complementarity-determining region 2 and framework region 3 sequences (<200 base pairs) of the rearranged immunoglobulin V(H) gene were obtained from polymerase chain reaction-amplified product, and the ratio of replacement-to-silent mutations and the frequency of intraclonal sequence variation were determined.
Clustering of replacement mutations in complementarity-determining region 2 with a high (>2.9) ratio of replacement-to-silent mutations was observed in 5 gastric DLBCLs, whereas it was recognized in only 1 intestinal DLBCL. Intraclonal sequence variation was observed in 6 intestinal and 5 gastric DLBCLs. The frequency of ongoing mutation was much higher in the intestinal (median, 0.33%) than in the gastric DLBCLs (median, 0.13%), but the difference was not statistically significant (P =.09).
The mutation pattern was consistent with positive antigen selection in gastric DLBCLs, but not in the intestinal tumors. Ongoing mutation was much more frequent in the intestinal than in the gastric DLBCLs. These findings suggest that positive antigen selection plays a major role in a significant proportion of gastric tumors, whereas germinal center reaction with aberrant mutation is important in small intestinal DLBCLs.
许多胃弥漫性大B细胞淋巴瘤(DLBCL)被认为代表黏膜相关淋巴组织型低度边缘区B细胞淋巴瘤的高级别转化,后者起源于记忆B细胞,显示出阳性抗原选择的证据以及重排的免疫球蛋白重链可变区(V(H))基因的低水平持续体细胞突变。肠道DLBCL中体细胞突变模式的研究较少。
为了评估抗原选择的证据和持续突变的水平,我们分析了置换突变与沉默突变的比例,以及在未伴有低度成分的胃和小肠DLBCL中克隆内序列变异的频率。
从胃(n = 6)和小肠(n = 6)DLBCL的福尔马林固定石蜡块中提取基因组DNA。从聚合酶链反应扩增产物中获得重排免疫球蛋白V(H)基因的互补决定区2和框架区3序列(<200个碱基对),并确定置换突变与沉默突变的比例以及克隆内序列变异的频率。
在5例胃DLBCL中观察到互补决定区2中置换突变的聚集,置换突变与沉默突变的比例较高(>2.9),而在仅1例肠道DLBCL中观察到这种情况。在6例肠道和5例胃DLBCL中观察到克隆内序列变异。肠道DLBCL中持续突变的频率(中位数,0.33%)远高于胃DLBCL(中位数,0.13%),但差异无统计学意义(P = 0.09)。
突变模式在胃DLBCL中与阳性抗原选择一致,但在肠道肿瘤中并非如此。肠道DLBCL中持续突变比胃DLBCL更频繁。这些发现表明,阳性抗原选择在相当一部分胃肿瘤中起主要作用,而生发中心反应伴异常突变在小肠DLBCL中很重要。